Abstract
This paper examines the use of language and metaphor in the reception of recombinant DNA in the USA between 1973 and 1988. The Archives of Stanford University are used to show how changing images of production were conveyed, and how academic–industrial policies were shaped, in a rapidly advancing field of biotechnology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Acknowledgements
An earlier version of this paper was presented at a Conference on Science and the Creation of Value held at the University of Uppsala, Sweden, in 2005. I thank the Columbia–Stanford Consortium on Biomedical Innovation, funded by the Merck Foundation, and the Association for Institutional Research. I am grateful to the Office of Technology Licensing at Stanford University for access to their archives. I am also grateful to Woody Powell, Roy MacLeod, and three Minerva reviewers for comments on earlier drafts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colyvas, J.A. Factory, Hazard, and Contamination: The Use of Metaphor in the Commercialization of Recombinant DNA. Minerva 45, 143–159 (2007). https://doi.org/10.1007/s11024-007-9036-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11024-007-9036-0